Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Xerri

Showing results (21-30 of 134) with videos related to

Pageof 14
Sort By:
American Journal of Clinical Pathology|October 1, 1995
Search for rearrangements and/or allelic loss of the fas/APO-1 gene in 101 human lymphomasL Xerri, N Carbuccia, P Parc, et al.
Human Pathology|May 1, 1994
Expression of the p53 gene in Hodgkin's disease: dissociation between immunohistochemistry and clinicopathological dataL Xerri, R Bouabdallah, J Camerlo, et al.
La Clinica Terapeutica|January 15, 1991
[Bacterial infections. Progress and new prospects in chemo-antibiotic therapy]A Olivieri, R Fostini, L Xerri, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1982
Experimental infections for the evaluation of beta-lactamase resistanceL Xerri, P Orsolini, E Erani, et al.
The Journal of Pathology|February 1, 1996
Molecular analysis of the NPM-ALK rearrangement in Hodgkin's diseaseL Xerri, P Parc, J Hassoun, et al.
Annales De Pathologie|January 1, 1991
[Genotypic analysis of malignant lymphomas]L Xerri, N Horschowski, J Gabert, et al.
Giornale Italiano Di Chemioterapia|January 1, 1979
[Cefuroxim. Importance of beta-lactamase resistance, evaluated in vitro and in vivo]L Xerri, P Orsolini, E Erani, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|April 1, 1988
Importance of inoculum growth phase when using an in vitro pharmacokinetic model to evaluate beta-lactam antibioticsL Xerri, R Broggio, B Caro, et al.
Giornale Italiano Di Chemioterapia|January 1, 1979
[Cefuroxime. Pharmacokinetic aspects in man after intravenous administration under different conditions]P Orsolini, L Xerri, P Vallaperta, et al.
Journal of Chemotherapy (Florence, Italy)|August 1, 1989
In-vitro activity of ofloxacin against Chlamydia trachomatisV Sambri, F Rumpianesi, L Xerri, et al.
Pageof 14

Showing results (21-30 of 134) with videos related to

Sort By:
Pageof 14
American Journal of Clinical Pathology|October 1, 1995
Search for rearrangements and/or allelic loss of the fas/APO-1 gene in 101 human lymphomasL Xerri, N Carbuccia, P Parc, et al.
Human Pathology|May 1, 1994
Expression of the p53 gene in Hodgkin's disease: dissociation between immunohistochemistry and clinicopathological dataL Xerri, R Bouabdallah, J Camerlo, et al.
La Clinica Terapeutica|January 15, 1991
[Bacterial infections. Progress and new prospects in chemo-antibiotic therapy]A Olivieri, R Fostini, L Xerri, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1982
Experimental infections for the evaluation of beta-lactamase resistanceL Xerri, P Orsolini, E Erani, et al.
The Journal of Pathology|February 1, 1996
Molecular analysis of the NPM-ALK rearrangement in Hodgkin's diseaseL Xerri, P Parc, J Hassoun, et al.
Annales De Pathologie|January 1, 1991
[Genotypic analysis of malignant lymphomas]L Xerri, N Horschowski, J Gabert, et al.
Giornale Italiano Di Chemioterapia|January 1, 1979
[Cefuroxim. Importance of beta-lactamase resistance, evaluated in vitro and in vivo]L Xerri, P Orsolini, E Erani, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|April 1, 1988
Importance of inoculum growth phase when using an in vitro pharmacokinetic model to evaluate beta-lactam antibioticsL Xerri, R Broggio, B Caro, et al.
Giornale Italiano Di Chemioterapia|January 1, 1979
[Cefuroxime. Pharmacokinetic aspects in man after intravenous administration under different conditions]P Orsolini, L Xerri, P Vallaperta, et al.
Journal of Chemotherapy (Florence, Italy)|August 1, 1989
In-vitro activity of ofloxacin against Chlamydia trachomatisV Sambri, F Rumpianesi, L Xerri, et al.
Pageof 14